Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, May 23 – 26 2022
17.05.2022 - Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that Mr. Darren ...
Source: wallstreet-online.de